tiprankstipranks
Plus Therapeutics Inc (PSTV)
NASDAQ:PSTV
US Market

Plus Therapeutics (PSTV) Income Statement

Compare
567 Followers

Plus Therapeutics Income Statement

Last quarter (Q3 2024), Plus Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Plus Therapeutics's net income was $-2.87M. See Plus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 4.91M$ 224.00K$ 0.00$ 303.00K$ 7.00M
Gross Profit
$ -4.78M$ -488.00K$ -66.00K$ -2.40M$ 1.63M
Operating Expenses
$ 8.54M$ 19.94M$ 12.43M$ 9.89M$ 10.65M
Depreciation and Amortization
$ 628.00K$ 712.00K$ 419.00K$ 369.00K$ 441.00K
EBITDA
$ -12.69M$ -18.85M$ -12.49M$ -6.76M$ -987.00K
Operating Income
$ -13.32M$ -19.71M$ -12.49M$ -9.58M$ -3.66M
Other Income/Expenses
$ 5.00K$ -563.00K$ -907.00K$ 1.34M$ 374.00K
Pretax Income
$ -13.32M$ -20.27M$ -13.40M$ -8.24M$ -3.28M
Net Income
$ -13.32M$ -20.84M$ -14.33M$ -9.35M$ -12.74M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.24$ -11.91$ -17.78$ -31.67$ -138.10
Diluted EPS
$ -4.24$ -11.91$ -17.78$ -31.67$ -138.10
Weighted Average Shares Outstanding
3.14M 1.75M 805.95K 295.19K 92.27K
Weighted Average Shares Outstanding (Diluted)
3.14M 1.75M 805.95K 295.19K 92.27K
Currency in USD

Plus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis